Perinatal-Onset Neuronopathic Gaucher Disease Is Refractory to High-Dose Ambroxol: A Case Report and Literature Review
Neonatology · 2025
DOI: 10.1159/000549536 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neonatology, 2025. Verfasst von Ryota Fujikawa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Gaucher Disease, Ambroxol. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Introduction
High-dose ambroxol is an effective pharmacological chaperone therapy for the systemic and neurological symptoms of Gaucher disease (GD). However, no clinical evidence of perinatal-onset GD has been documented. Case Presentation: The patient had perinatal-onset neuronopathic GD (PnGD) and received high-dose ambroxol, beginning at 10 days of life after a newborn screening report. There was a transient hematological response after combined ambroxol and enzyme replacement therapy; however, laryngospasm, epileptic seizures, liver dysfunction, and heart failure progressed. The patient died 95 days after birth. Genetic testing revealed a homozygous L483R variant in GBA1. A literature review of 56 patients with nGD confirmed poor survival outcomes for patients with PnGD.
Conclusion
Ambroxol therapy may be insufficient to improve the prognosis of patients with PnGD, underscoring the limitations of early intervention in newborn-screened patients with GD. Therefore, pre-emptive therapeutic strategies are required to rescue and cure neonates with PnGD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Department of Pediatrics, NHO Kokura Medical Center, Kitakyushu, Japan.
- Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, egami.naoki.063@m.kyushu-u.ac.jp.
- Department of Pediatrics, Fukuoka Red Cross Hospital, Fukuoka, Japan.
- Department of Pediatrics, NHO Kyushu Medical Center, Fukuoka, Japan.
- Research Center for Environmental and Developmental Medical Sciences, Kyushu University, Fukuoka, Japan.
Zitieren
APA
Fujikawa, R., Egami, N., Mikubo, R., Kajiwara, K., Tocan, V., Igata, Y., Miyauchi, Y., Yasuoka, K., Sakai, Y., Mushimoto, Y., Ochiai, M., Inoue, H., & Ohga, S. (2025). Perinatal-Onset Neuronopathic Gaucher Disease Is Refractory to High-Dose Ambroxol: A Case Report and Literature Review. Neonatology. https://doi.org/10.1159/000549536
Vancouver
Fujikawa R, Egami N, Mikubo R, Kajiwara K, Tocan V, Igata Y, et al. Perinatal-Onset Neuronopathic Gaucher Disease Is Refractory to High-Dose Ambroxol: A Case Report and Literature Review. Neonatology. 2025. doi:10.1159/000549536
BibTeX
@article{Fujikawa2025,
author = {Fujikawa, Ryota and Egami, Naoki and Mikubo, Ryoji and Kajiwara, Kenta and Tocan, Vlad and Igata, Yuhei and Miyauchi, Yuta and Yasuoka, Kazuaki and Sakai, Yasunari and Mushimoto, Yuichi and Ochiai, Masayuki and Inoue, Hirosuke and Ohga, Shouichi},
title = {Perinatal-Onset Neuronopathic Gaucher Disease Is Refractory to High-Dose Ambroxol: A Case Report and Literature Review},
journal = {Neonatology},
year = {2025},
doi = {10.1159/000549536}
}
EUVIMED